MedicaidCoverageMedium impact
Coverage of At Home COVID-19 Over-the-Counter Test Kits pdf
Connecticut Medicaid (HUSKY Health)·CT·Provider Bulletin
Effective date
Dec 1, 2021
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid (CMAP) now covers FDA-approved at-home COVID-19 test kits through pharmacy point-of-sale billing, with no prescription required. Coverage is limited to 8 tests per member per 30-day period for all HUSKY members, with no copayments for HUSKY B members.
Action Required
Immediately: Pharmacy billing staff must update systems to process at-home COVID-19 test kit claims through point-of-sale for CMAP members. Use pharmacist NPI as prescribing provider NPI when no prescription exists. Ensure no copayments are collected from HUSKY B members. Limit coverage to 8 tests per member per 30-day period without prior authorization.